Abstract 1036: Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition

Abstract

Abstract Although protein arginine methyltransferase 5 (PRMT5) has been implicated in various cancers, its expression pattern in lung adenocarcinoma cell lines and tissue samples has not yet been elucidated in detail. In this study, microarray data analysis of 40 non-small cell lung carcinoma cell lines showed that PRMT5 was a candidate histone methyltransferase gene that correlated with epithelial-mesenchymal transition. Immunocytochemical analysis of these cell lines indicated that the expression of PRMT5 was frequently localized to the cytoplasm of E-cadherin-low and vimentin-high cell lines, while it was predominant in the nucleus and faint in the cytoplasm of E-cadherin-high and vimentin-low cell lines. Immunohistochemical analysis of 130 cases of lung adenocarcinoma revealed that the expression of PRMT5 was high in the cytoplasm of 47 cases (36%) and the nuclei of 34 cases (26%). The high cytoplasmic expression of PRMT5 was frequently observed in high grade subtypes such as the solid adenocarcinoma component with low expression of thyroid transcription factor-1 (TTF-1, the master regulator of lung) and low expression of cytokeratin 7 and E-cadherin (two markers for bronchial epithelial differentiation), while the high nuclear expression of PRMT5 was frequently noted in the lepidic growth component, a low-grade subtype. The cytoplasmic expression of PRMT5 was correlated with vessel invasion and poor prognosis. We herein highlighted the importance of PRMT5 expression, especially its cytoplasmic expression, in the process of epithelial-mesenchymal transition and loss of the bronchial epithelial phenotype of lung adenocarcinoma. Citation Format: Daisuke Matsubara, Reem Ibrahim, Wael Osman, Akteru Goto, Teppei Morikawa, Shigeki Morita, Shumpei Ishikawa, Hiroyuki Aburatani, Masashi Fukayama, Toshiro Niki, Yoshinori Murakami. Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 1036. doi:10.1158/1538-7445.AM2014-1036